CollPlant Biotechnologies (CLGN) EPS (Basic) Growth (5y) (2022 - 2026)
CollPlant Biotechnologies (CLGN) EPS (Basic) Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - |
| 10 | CollPlant Biotechnologies | 4.14 Mn | 4.14 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -1,638.64% |
| Dec 31, 2025 | -2,599.11% |
| Sep 30, 2025 | -2,761.75% |
| Jun 30, 2025 | -10.09% |
| Mar 30, 2025 | -1,990.47% |
| Dec 31, 2024 | -19.69% |
| Sep 30, 2024 | -20.83% |
| Jun 30, 2024 | -95.87% |
| Mar 31, 2024 | -96.32% |
| Dec 31, 2023 | -28.50% |
| Sep 30, 2023 | -27.98% |
| Jun 30, 2023 | -95.83% |
| Mar 31, 2023 | -96.57% |
| Dec 31, 2022 | -96.46% |